Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors

Laboratory Investigation

Volumn 76, Issue 4, 1997, Pages 497-504

  Pera, Martin F ^a,b   Bennett, William ^a   Cerretti, Douglas P ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ARTICLE; EMBRYO; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MEMBRANE BINDING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030909377     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJL, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi PS, Penninger JM, and Mak TW (1996). Impaired negative selection of T-cells in Hodgkins-disease antigen CD30-deficient mice. Cell 84:551-562.
2. Andrews PW (1988). Human teratocarcinomas. Biochim Biophys Acta 948:17-36.
3. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, and Stein H (1992). Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421-427.
4. Ferreiro JA (1994). Ber-h2 expression in testicular germ-cell tumors. Hum Pathol 25:522-524.
5. Fonatsch C, Latza U, Dürkop H, Rieder H, and Stein H (1992). Assignment of the human CD30 (KI-1) gene to 1 p36. Genomics 14:825-826.
6. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, and Goodwin RG (1994). Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell-lines. Blood 83: 2045-2056.
7. Ito K, Watanabe T, Horie R, Shiota M, Kawamura S, and Mori S (1994). High expression of the cd30 molecule in human decidual cells. Am J Pathol 145:276-280.
8. Latza U, Foss HD, Durkop H, Eitelbach F, Dieckmann KP, Loy V, Unger M, Pizzolo G, and Stein H (1995). Cd3O antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. Am J Pathol 146:463-471.
9. Meier T, Ami S, Malarkannan S, Poincelet M, and Hoessli D (1992). Immunodetection of biotinylated lymphocyte-surface proteins by enhanced chemiluminescence: A non-radioactive method for cell-surface protein analysis. Anal Biochem 204: 220-226.
10. Pallesen G and Hamilton-Dutoit SJ (1988). Ki-1 (CD30) is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol 133:446-450.
11. Pera MF, Blasco-Lafita MJ, and Mills J (1987). Cultured cell lines from human testicular teratomas: The nature of human embryonal carcinoma, and its comparison with two types of yolk sac carcinoma. Int J Cancer 40:334-343.
12. Pera MF, Blascolafita MJ, Cooper S, Mason M, Mills J, and Monaghan P (1988). Analysis of cell-differentiation lineage in human teratomas using new monoclonal-antibodies to cytostructural antigens of embryonal carcinoma-cells. Differentiation 39:139-149.
13. Pera MF, Cooper S, Mills J, and Parrington JM (1989). Isolation and characterization of a multipotent clone of human embryonal carcinoma-cells. Differentiation 42:10-23.
14. Pera MF, Roach S, and Elliss CJ (1990). Comparative biology of mouse and human embryonal carcinoma. Cancer Surv 9:243-262.
15. Roach S, Cooper S, Bennett W, and Pera MF (1993). Cultured cell lines from human germ cell tumours: Windows into tumour growth and differentiation and early human development. Eur Urol 23:82-88.
16. Roach S, Schmid W, and Pera MF (1994). Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell-lines: Expression of HNF-3- alpha in models of early endodermal cell-differentiation. Exp Cell Res 215:189-198.
17. Roderiguez E, Mathew S, Reuter VE, Ilson DH, Bosl GJ, and Chaganti RS (1992). Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 52: 2285-2291.
18. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner HH, Schaadt M, and Diehl V (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65-67.
19. Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, and Stein H (1989). Ber-H2, a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74: 1678-1689.
20. Smith CA, Farrah T, and Goodwin RG (1994). The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959-962.
21. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan Cl, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, Mcalister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, and Armitage RJ (1993). CD30 antigen, a marker for Hodgkins lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349-1360.
22. Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, and Hearn JP (1995). Isolation of a primate embryonic stem-cell line. Proc Natl Acad Sci USA 92:7844-7848.
23. Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, and Hearn JP (1996). Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol Reprod 55: 254-259.